Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

Specimen Handling 5Nivolumab 5Magnetic Resonance Spectroscopy 4pembrolizumab 3Biopsy 3dehydroftorafur 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Proctoscopy 2Paclitaxel 2Mitozytrex 2Mitomycin 2Fluorouracil 2Fluorodeoxyglucose F18 2Colonoscopy 2Carboplatin 2Capecitabine 2trastuzumab deruxtecan 1entinostat 1bintrafusp alfa protein, human 1X-Rays 1Watchful Waiting 1Tomography, X-Ray Computed 1Taxes 1Surveys and Questionnaires 1Sentinel Lymph Node Biopsy 1Radiotherapy 1Radionuclide Imaging 1Radiation 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Dehydroepiandrosterone × 90 days × Clear all
NCT07407647 2026-04-21

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
25 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡